title: [Quantitative analysis of plasma concentration of barbiturate for diagnosis of brain death].
abstract: Organ transplantation from brain death patients started in Japan in 1997. However it is difficult to diagnose brain death in patients treated with barbiturate therapy. In this study, the influence of long continuous administration of barbiturate on diagnosis of brain death was investigated by measuring plasma concentration of barbiturate. In 15 patients treated with barbiturate therapy, plasma concentrations of thiamylal were measured by liquid chromatographic apparatus every day until it's level decreased below 0.1 microgram/ml after cessation of continuous administration. At the same time, plasma thiamylal levels were checked on the day when burst-suppression (b-s) pattern had disappeared in 9 cases, light reflex of pupil appeared in 7 cases and spontaneous respiration had been detected by trigger lamp in 11 cases. The plasma concentrations of thiamylal on the day when b-s pattern had disappeared differed clearly among the cases in the range of 8.8 to 37.9 micrograms/ml. Those cases in which light reflex of the pupil had been recognized were also different in the range of 17.8 to 57.8 micrograms/ml. The cases in which spontaneous respiration had been detected were in the range of 4.4 to 23.0 micrograms/ml. These concentrations varied about 4, 3 and 5 times among the cases examined. The intervals between cessation of continuous administration of thiamylal and the decrease of plasma concentration to below 0.1 microgram/ml also varied from 2 to 14 days from case to case. The minimum concentration of thiamylal on the day when b-s pattern had disappeared, light reflex of the pupil had been recognized and spontaneous respiration had been detected was 8.8, 17.8 and 4.4 micrograms/ml respectively. These results suggest that diagnosis of brain death in patients treated with barbiturate therapy is able to be made when the plasma thiamylal level is below 4.4 micrograms/ml.
authors.affiliation: Department of Neurosurgery, Nagano Red Cross Hospital, 5-22-1 Wakasato, Nagano 380-8582, Japan.
authors.forename: Takafumi
authors.initials: T
authors.lastname: Saito
authors.forename: Akihiko
authors.initials: A
authors.lastname: Kurashima
authors.forename: Tazunu
authors.initials: T
authors.lastname: Oda
authors.forename: Satoshi
authors.initials: S
authors.lastname: Aoki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Endo
authors.forename: Takeo
authors.initials: T
authors.lastname: Nashimoto
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Yamada
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001463:Barbiturates / Q000097:blood* / Q000627:therapeutic use; D001926:Brain Death / Q000097:blood* / Q000175:diagnosis*; D002648:Child; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013840:Thiamylal / Q000097:blood* / Q000627:therapeutic use
chemical_list: D001463:Barbiturates; D013840:Thiamylal